7 October, 2026 Melbourne, Australia CSL prices US$1.5 billion in Corporate Bonds CSL Limited (ASX:CSL; USOTC:CSLLY) today announces it has priced US$1.5 billion of corporate bonds in the US Dollar 144A / Reg S market. The notes will be issued by CSLB Holdings Inc. and guaranteed by the parent...
CSL prices US$1.5 billion in Corporate Bonds
Filed with ASX · · 2 pages · English
Summary by 6ix AI
The bonds will be issued by CSLB Holdings Inc. and guaranteed by CSL Limited and certain subsidiaries. The proceeds from this offering will be used to refinance existing debt and for general corporate purposes.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Watch CSL's latest callCSL (ASX:CSL) Q4 2026 Earnings Call · Replay · Aug 18Read the transcript of CSL (ASX:CSL) Q4 2026 Earnings CallRelease
Earlier from CSL
- CSL and Alentis announce global partnership to develop and commercialise lixudebart for rare kidney and liver diseases
- CSL และ Alentis ประกาศความร่วมมือระดับโลก เพื่อพัฒนาและทำการตลาดยา lixudebart สำหรับโรคไตและตับที่พบได้ยาก
- CSL enters exclusive agreement with Alentis Therapeutics
- CSL Seqirus Expands U.S. Availability of Influenza Vaccine following Successful Completion of the 2026/27 Manufacturing Campaign
- Update - Notification of buy-back - CSL
Later from CSL
- CSL dan Alentis umum perkongsian global untuk membangunkan dan mengkomersialkan lixudebart bagi penyakit buah pinggang dan hati yang jarang berlaku
- Update on U.S. Plasma Collection Network
- Appointment of New CEO
- CSL appoints Deborah Waterhouse as CEO & Managing Director
- CSL to Defend Class Action
Follow CSL into a list and get an email when it puts out news.
Follow CSL